TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
MRNA

Moderna Inc

Healthcare · Biotechnology

172.90$ +12.3% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Balance Sheet

All figures as a percentage of total assets in the same period.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MRNA
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
27.3% 100.0% 76.7% 72.2% 79.7% 71.0% 85.8% 65.1% 51.9% 56.0% 57.3% 53.0%
19.8% 100.0% 3.5% 12.4% 33.6% 14.8% 35.8% 27.8% 12.4% 15.8% 13.6% 21.0%
74.7% 69.7% 86.4% 69.4% 62.8% 43.5% 38.3% 46.7% 49.7% 47.0%
5.4% 1.3% 1.5% 1.6% 1.0% 19.2% 13.5% 6.5% 5.9% 4.2% 2.3%
-8.8% -56.9% 0.6% 5.8% 3.7% 1.1% 0.8% 1.2%
5.7% 12.8% 10.8% 18.1% 5.3% 5.6% 8.3%
0.3% 0.3% 0.0% 0.3% 0.4% 0.4%
72.7% 0.2% 0.2% 0.2% 0.3% 0.4%
147.4% 65.6% 40.6% 42.3% 22.0% 26.1% 65.1% 42.7% 26.0% 24.8% 22.9% 29.9%
21.1% 51.6% 11.5% 17.7% 11.4% 9.0% 59.8% 37.0% 19.0% 16.4% 15.6% 16.1%
1.8% 6.7% 4.0% 4.3% 0.4% 0.9% 0.8% 0.1% 0.3%
21.1% 4.2% 2.0% 1.9% 1.6% 0.4% 0.2% 1.2% 1.9% 2.8% 2.9% 2.6%
0.9% 1.4% 4.8%
-47.4% 34.4% 59.4% 57.7% 78.0% 73.9% 34.9% 57.3% 74.0% 75.2% 77.1% 70.1%
-3,665.2% -425.4% -25.8% -57.3% -51.3% -94.2% -30.6% 40.4% 70.8% 73.8% 71.0% 58.5%
23,296.0% 26.5% 34.7% 4.1% 20.8% 5.2% 1.7% 1.6% 2.1% 2.7% 3.2%

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?